trial · primary record
fenfluramine hydrochloride
Rett Syndrome
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2031-08-29 |
| Primary endpoint | Change from Baseline to Week 14 in Rett Syndrome Behaviour Questionnaire (RSBQ) Total Score |
| Registry ID | NCT07503444 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.864Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07503444
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Fenfluramine Hydrochloride · approval
- fenfluramine hydrochloride · compound